Ethambutol Toxicity: Key Clinical Features
Recommendation: The hallmark and most morbid feature is toxic optic neuropathy (optic/retrobulbar neuritis) presenting with painless, bilateral (often symmetric) decreased visual acuity, red–green dyschromatopsia, central or cecocentral scotomas, and visual field defects; any such symptom warrants immediate cessation of ethambutol and urgent ophthalmologic evaluation to prevent irreversible vision loss. 1, 2, 3, 4, 5
Core Ocular Manifestations (dose- and duration-dependent; higher risk with renal impairment)
- Decreased visual acuity (may be unilateral early, typically bilateral) 1, 2
- Dyschromatopsia, classically red–green color vision loss 2, 4
- Central/cecocentral scotomas; peripheral field defects can occur 2, 3
- Painless, subacute onset over weeks to months; may precede measurable test changes—patients often notice symptoms first 3, 2
- Generally reversible if detected early and drug stopped; irreversible blindness reported if unrecognized/continued 1, 5
- Nuance: Ethambutol toxicity can involve retina as a neuroretinopathy (rare macular edema, RPE changes), but clinical syndrome is dominated by optic neuropathy features 6
Non-ocular Features (less common; important caveats)
- Peripheral neuropathy (numbness/tingling) – rare 2
- Hyperuricemia and acute gout flares 1
- Cutaneous hypersensitivity reactions (rash, pruritus; rarely severe) 2, 1
- GI upset (nausea, vomiting, abdominal pain), anorexia 1
- Systemic: fever, malaise, headache, dizziness; rare hematologic cytopenias 1
- Hypersensitivity syndrome (rash ± eosinophilia with hepatitis, pneumonitis, nephritis, myocarditis/pericarditis) 1
- Reported liver toxicity, including rare fatalities; monitor if clinically indicated 1
High-Risk Situations and Pitfalls
- Higher daily doses (>15–25 mg/kg) and prolonged therapy: greater ocular toxicity risk; daily high-dose regimens >30 mg/kg especially risky 2
- Renal insufficiency: accumulation increases ocular toxicity risk; dosing must be adjusted 2
- Long NTM courses have higher ocular toxicity rates than typical TB durations 3, 4
- Pitfall: Waiting for objective test changes—symptoms often precede test abnormalities; act on symptoms immediately 3, 2
Practical Bedside Triggers to Stop Ethambutol Immediately (protect vision, QOL)
- New blurred vision, difficulty reading fine print, or dimming of vision 1, 2
- New color vision problems, especially red–green confusion 2
- Central blind spots or reduced contrast sensitivity reported by the patient 2, 3
Monitoring notes to prevent morbidity: